Style | Citing Format |
---|---|
MLA | Mehraeen E, et al.. "Covid-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice." Infectious Disorders - Drug Targets, vol. 22, no. 5, 2022, pp. 47-57. |
APA | Mehraeen E, Oliaei S, Seyedalinaghi S, Karimi A, Mirzapour P, Afsahi AM, Barzegary A, Vahedi F, Soleymanzadeh M, Behnezhad F, Javaherian M, Zargari G, Mirghaderi SP, Noori T, Sabatier JM (2022). Covid-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice. Infectious Disorders - Drug Targets, 22(5), 47-57. |
Chicago | Mehraeen E, Oliaei S, Seyedalinaghi S, Karimi A, Mirzapour P, Afsahi AM, Barzegary A, et al.. "Covid-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice." Infectious Disorders - Drug Targets 22, no. 5 (2022): 47-57. |
Harvard | Mehraeen E et al. (2022) 'Covid-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice', Infectious Disorders - Drug Targets, 22(5), pp. 47-57. |
Vancouver | Mehraeen E, Oliaei S, Seyedalinaghi S, Karimi A, Mirzapour P, Afsahi AM, et al.. Covid-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice. Infectious Disorders - Drug Targets. 2022;22(5):47-57. |
BibTex | @article{ author = {Mehraeen E and Oliaei S and Seyedalinaghi S and Karimi A and Mirzapour P and Afsahi AM and Barzegary A and Vahedi F and Soleymanzadeh M and Behnezhad F and Javaherian M and Zargari G and Mirghaderi SP and Noori T and Sabatier JM}, title = {Covid-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice}, journal = {Infectious Disorders - Drug Targets}, volume = {22}, number = {5}, pages = {47-57}, year = {2022} } |
RIS | TY - JOUR AU - Mehraeen E AU - Oliaei S AU - Seyedalinaghi S AU - Karimi A AU - Mirzapour P AU - Afsahi AM AU - Barzegary A AU - Vahedi F AU - Soleymanzadeh M AU - Behnezhad F AU - Javaherian M AU - Zargari G AU - Mirghaderi SP AU - Noori T AU - Sabatier JM TI - Covid-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice JO - Infectious Disorders - Drug Targets VL - 22 IS - 5 SP - 47 EP - 57 PY - 2022 ER - |